BHC
6007217.032.63% ( +0.18 )
BHC (600721)
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other busi...
- Open
- 6.91
- High
- 7.04
- Low
- 6.85
- Prev. Close
- 6.85
- Volume
- 130.65K
- Turnover
- 91.24M
- Avg Price
- 6.98
- Bid/Ask Ratio
- 19.66%
- Amplitude
- 2.77%
- 52wk High
- 12.56
- Volume Ratio
- 0.32
- Turnover Ratio
- 3.40%
News
- Wallstreetcn · Mar 25 at 08:35 PM
Innovative drug concept stocks continue to be strong, with Menovo hitting a 3-day consecutive limit up, followed by Fushine, BHC, Kingchem, APELOA, and WuXi AppTec
- Wallstreetcn · Mar 23 at 08:42 PM
CRO concept stocks fluctuated and strengthened, with Fushine and Menovo both hitting the daily limit, Kingchem rising more than 10%, and Biocytogen, BHC, and ChemPartner following suit
- Zhitong · Oct 27, 2025 at 05:27 AM
BHC: The net profit for the third quarter was 7.1908 million yuan, a year-on-year increase of 456.45%
- Zhitong · Sep 2, 2025 at 09:53 PM
The concept of innovative drugs rebounds, BHC and HWHG hit the limit up
- Zhitong · Aug 21, 2025 at 04:19 AM
BHC released its performance for the first half of the year, with a net profit attributable to the parent company of 25.4834 million yuan, a year-on-year increase of 12.45%
- Zhitong · Aug 17, 2025 at 08:59 PM
The concept of weight loss drugs continues to strengthen, BHC hits the daily limit
